ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2208

Diagnostic Performance of Hip Ultrasound in Calcium Pyrophosphate Deposition Disease

Carina Soto-Fajardo1, Fabian Carranza-Enriquez2, Sinthia Solorzano Flores2, Abish Angeles2, Paola Flores2, Raul Pichardo-Bahena2, Luis Javier Jara Quezada2, Angélica Peña Ayala2, Victor-Manuel Ilizaliturri-Sanchez2, Georgios Filippou3 and Carlos Pineda2, 1Instituto Nacional de Rehabilitacion "Luis Guillermo Ibarra Ibarra", Ciudad de México, Mexico, 2Instituto Nacional de Rehabilitacion, Ciudad de México, Mexico, 3Rheumatology Department, Luigi Sacco University Hospital, Siena, Italy

Meeting: ACR Convergence 2022

Keywords: CCP, Crystal-induced arthritis, OMERACT, Osteoarthritis, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2022

Title: Abstracts: Imaging of Rheumatic Diseases

Session Type: Abstract Session

Session Time: 3:00PM-4:30PM

Background/Purpose: Calcium Pyrophosphate Deposition Disease (CPPD) is a chronic and potentially incapacitating disease. The reference standard for its diagnosis is the identification of calcium pyrophosphate (CPP) crystals in synovial fluid. Ultrasound (US) has been proven to be a high sensibility and specificity tool for the diagnosis of CPPD, but it has not yet been determined its diagnostic performance for hip involvement. The aim of this research is to evaluate the diagnostic performance of US compared with synovial fluid analysis and histopathology (hyaline cartilage, fibrocartilage, synovial membrane) for the identification of hip CPP deposits.

Methods: Patients older than 50 years old with osteoarthritis programed for hip replacement surgery in a referral hospital. Patients with a primary rheumatologic disease were excluded. A pre-surgical US of the affected hip was performed with a LOGIQTMe device and a convex transducer (2-5 MHz); the anatomical structures evaluated were the acetabular fibrocartilage (FC) and the hyaline cartilage of the femoral head (HC), video tracking was recorded and a dichotomic score was assigned to determine the presence or absence of CPP deposits (in line with OMERACT definitions). During surgery, a sample of hip synovial fluid was obtained and examined using polarized light microscopy. After the surgery an experimented pathologist examined the FC and HC in search for CPP crystals.

Results: 67 patients were included, 55.2% were women with a mean age of 64±7.9 years. A frequency of 82% (55/67) of CPP deposits was found through US examination, of which 29/67 (43.3%) where found on FC and 42/67(62.7%) were found on HC. Regarding pathology evaluation, a prevalence of 93.9% of CPP crystals was found, 83.6% (56/67) were found on FC and 86.6% (58/67) on HC. 24% of patients had synovial effusion and 3% had synovial hypertrophy. Synovial fluid was obtained in 64.2% (43/67) of patients, with a median volume of 0.8mL (IQR 0.45-1.15mL), CPP crystals were found in 14.9% (10/43) of samples. Chondrocalcinosis in XR was found in 14.9% (10/67). A sensitivity of 85% and a specificity of 75% were obtained, the positive predictive value was 98% and the negative predictive value was 25%. The area under the curve for US compared with histopathology for the diagnosis of hip CPPD was 0.80 (CI 95% 0.55-1) (Figure 1).

Conclusion: US is a valid imaging method with good diagnostic performance for the diagnosis of CPPD in the coxofemoral joint.

Supporting image 1

Figure 1. ROC curve of US


Disclosures: C. Soto-Fajardo, None; F. Carranza-Enriquez, None; S. Solorzano Flores, None; A. Angeles, None; P. Flores, None; R. Pichardo-Bahena, None; L. Jara Quezada, None; A. Peña Ayala, None; V. Ilizaliturri-Sanchez, None; G. Filippou, None; C. Pineda, None.

To cite this abstract in AMA style:

Soto-Fajardo C, Carranza-Enriquez F, Solorzano Flores S, Angeles A, Flores P, Pichardo-Bahena R, Jara Quezada L, Peña Ayala A, Ilizaliturri-Sanchez V, Filippou G, Pineda C. Diagnostic Performance of Hip Ultrasound in Calcium Pyrophosphate Deposition Disease [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/diagnostic-performance-of-hip-ultrasound-in-calcium-pyrophosphate-deposition-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/diagnostic-performance-of-hip-ultrasound-in-calcium-pyrophosphate-deposition-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology